BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Structure Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-20 4:36 pm Sale | 2023-12-18 | 13G | Structure Therapeutics Inc. GPCR | BIOTECHNOLOGY VALUE FUND L P | 2,438,964 1.800% | -10,221,554 (-80.74%) | Filing |
| 2023-02-13 5:28 pm Purchase | 2023-02-03 | 13G | Structure Therapeutics Inc. GPCR | BIOTECHNOLOGY VALUE FUND L P | 12,660,518 11.100% | 12,660,518 (New Position) | Filing |